NTX-470

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameNTX-470

Drug Alias NameNTX-0470NTX-470

ClassificationCell and gene therapy > Gene therapy > mRNABiologics > T cell engagers

Mechanisms of ActionT cell surface glycoprotein CD3 modulatorsSix-transmembrane epithelial antigen of the prostate 1modulatorsProstate-specific antigen modulators

TargetsT cell surface glycoprotein CD3Six-transmembrane epithelial antigen of the prostate 1Prostate-specific antigen

Therapy Area/IndicationsUrologic Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesNutcracker Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesNutcracker Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsUrologic Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A